Holen Sie sich die Stockscreener-App
14.05
2.29%
0.315
Handel nachbörslich:
13.80
-0.25
-1.78%
Schlusskurs vom Vortag:
$13.73
Offen:
$13.74
24-Stunden-Volumen:
531.88K
Relative Volume:
1.55
Marktkapitalisierung:
$707.58M
Einnahmen:
$62.02M
Nettoeinkommen (Verlust:
$-45.65M
KGV:
-15.27
EPS:
-0.92
Netto-Cashflow:
$-9.60M
1W Leistung:
+0.57%
1M Leistung:
+25.22%
6M Leistung:
+54.40%
1J Leistung:
+74.75%
1-Tages-Spanne:
$13.66
$14.09
1-Wochen-Bereich:
$13.66
$14.55
52-Wochen-Spanne:
$7.88
$14.55
Theravance Biopharma Inc Stock (TBPH) Company Profile
Firmenname
Theravance Biopharma Inc
Sektor
Branche
Telefon
650-808-6000
Adresse
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Vergleichen Sie TBPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TBPH
Theravance Biopharma Inc
|
14.05 | 697.00M | 62.02M | -45.65M | -9.60M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-06 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-04-12 | Eingeleitet | BTIG Research | Buy |
| 2024-01-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-05-23 | Eingeleitet | SVB Leerink | Outperform |
| 2021-11-05 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2021-08-25 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2021-08-24 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-10-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-07 | Eingeleitet | JP Morgan | Overweight |
| 2020-06-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-05-13 | Eingeleitet | Cowen | Outperform |
| 2020-01-08 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-06 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2019-10-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-29 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-06-16 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-05-11 | Bestätigt | Needham | Buy |
| 2016-12-21 | Eingeleitet | Needham | Buy |
| 2016-11-03 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-10-12 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2016-08-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2016-06-20 | Eingeleitet | Guggenheim | Buy |
| 2016-06-20 | Bestätigt | Leerink Partners | Outperform |
| 2016-05-12 | Eingeleitet | Leerink Partners | Outperform |
| 2016-05-05 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2015-02-03 | Hochstufung | Robert W. Baird | Underperform → Neutral |
Alle ansehen
Theravance Biopharma Inc Aktie (TBPH) Neueste Nachrichten
Can momentum traders help lift Theravance Biopharma Inc.Quarterly Portfolio Report & Reliable Breakout Forecasts - Newser
Trend Report: How volatile is Theravance Biopharma Inc. stock2025 Stock Rankings & Consistent Growth Equity Picks - khodrobank.com
Has Theravance Biopharma Inc. formed a bullish divergence2025 Bull vs Bear & Growth Focused Entry Point Reports - Newser
Predicting Theravance Biopharma Inc. trend using moving averages2025 Support & Resistance & Fast Gaining Stock Reports - Newser
Does Theravance Biopharma Inc. qualify in momentum factor screening2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
Is Theravance Biopharma Inc. stock ready for a breakout2025 Dividend Review & Technical Buy Zone Confirmation - Newser
Tools to assess Theravance Biopharma Inc.’s risk profile2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
How high can Theravance Biopharma Inc. stock goRisk Management & Reliable Volume Spike Trade Alerts - Newser
Is Theravance Biopharma Inc. a momentum stock2025 Retail Activity & Capital Efficiency Focused Ideas - khodrobank.com
Will Theravance Biopharma Inc. benefit from rising consumer demand2025 Key Highlights & Growth Focused Entry Reports - khodrobank.com
Using data tools to time your Theravance Biopharma Inc. exitDollar Strength & High Return Stock Watch Alerts - Newser
What’s the recovery path for long term holders of Theravance Biopharma Inc.Portfolio Update Report & Growth Oriented Trading Recommendations - Newser
Can Theravance Biopharma Inc. be recession proofMarket Volume Summary & Technical Confirmation Alerts - khodrobank.com
Is Theravance Biopharma Inc. a speculative investmentWeekly Volume Report & Risk Controlled Daily Trade Plans - khodrobank.com
Published on: 2025-09-02 12:17:38 - Newser
Is Theravance Biopharma Inc. on track to beat earningsJuly 2025 Highlights & Free Safe Capital Growth Stock Tips - khodrobank.com
Detecting price anomalies in Theravance Biopharma Inc. with AIJuly 2025 Earnings & Real-Time Volume Analysis - Newser
Theravance Biopharma to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Citizen Tribune
Theravance Biopharma to Present at H.C. Wainwright 27th Annual Global Investment Conference. - AInvest
Biotech Leader Theravance Biopharma Featured at Major H.C. Wainwright Global Investment Conference - Stock Titan
Is Theravance Biopharma Inc. stock undervalued right now2025 Risk Factors & Verified Short-Term Trading Plans - khodrobank.com
Published on: 2025-09-02 03:55:39 - khodrobank.com
Aug EndMonth: How is Theravance Biopharma Inc. managing supply chain issuesMarket Volume Summary & Fast Moving Stock Trade Plans - khodrobank.com
Will Theravance Biopharma Inc. benefit from AI trendsJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - khodrobank.com
Theravance Biopharma Inc. stock daily chart insightsMarket Sentiment Summary & Proven Capital Preservation Methods - Newser
Trendlines Converge — Decision Point for Theravance Biopharma Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Using economic indicators to assess Theravance Biopharma Inc. potentialQuarterly Profit Review & Verified Momentum Watchlists - Newser
Earnings visualization tools for Theravance Biopharma Inc.Weekly Market Outlook & Daily Volume Surge Trade Alerts - Newser
Are Bears Losing Grip on Theravance Biopharma Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Published on: 2025-08-31 03:27:33 - Newser
Risk vs reward if holding onto Theravance Biopharma Inc.2025 Short Interest & Real-Time Volume Spike Alerts - Newser
Is Theravance Biopharma Inc. stock a good hedge against inflationWeekly Gains Report & High Accuracy Trade Signal Alerts - Newser
Is Theravance Biopharma Inc. trending in predictive chart modelsJuly 2025 Momentum & Consistent Profit Alerts - Newser
Finanzdaten der Theravance Biopharma Inc-Aktie (TBPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):